health_en | Page 57 of 128

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML

Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutation Assay as the companion diagnostic for Daiichi Sankyo’s investigational drug quizartinib. The assay is used for the identification of […]

25 ต.ค. 65 9:00

thaipr.net

25 ต.ค. 65

AFTER 30 YEARS — NEW GUIDELINES FOR WEIGHT-LOSS SURGERY

Medical Groups Replace Outdated Consensus Statement that Overly Restricts Access to Modern-Day Weight-Loss Surgery Two of the world’s leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss surgery and endorse metabolic surgery for patients with type 2 diabetes beginning at a […]

25 ต.ค. 65 8:08

thaipr.net

25 ต.ค. 65

Faculty of Medical Technology, Mahidol University held the launching event of CANDEE Application

Blockchain Technology is an encrypted database shared by several parties in a distributed network. It is a fact that blockchain technology has already been used in multiple industries as a means of…

21 ต.ค. 65 13:53

thaipr.net

21 ต.ค. 65

MGI Contributes to Thailand’s Roadmap for Genomic Medicine in Genomics Thailand Initiative

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the supply of its products* to support the sequencing of the genomes of 50,000 Thai individuals as part of the Genomics Thailand Initiative, which focuses on increasing the country’s competitiveness in genomic medicine research and […]

21 ต.ค. 65 10:30

thaipr.net

21 ต.ค. 65

MedAlliance to be Acquired by Cordis

Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of $200M, regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029 for a total consideration of up to $1.135 […]

20 ต.ค. 65 16:05

thaipr.net

20 ต.ค. 65

Grand Opening of ‘Medlab Asia & Asia Health 2022’ in Thailand

Thailand’s Minister of Public Health officiates Medlab Asia & Asia Health 2022, the leading trade exhibition within the medical laboratory industry in the ASEAN region, organised by Informa…

20 ต.ค. 65 15:502022-10-20

thaipr.net

20 ต.ค. 65

Grand Opening of ‘Medlab Asia & Asia Health 2022’ The first day of the event more than 5,000 participants, expected to generate business over 700 million Baht

Minister of Public Health officiates Medlab Asia & Asia Health 2022, the leading trade exhibition within the medical laboratory and healthcare industry in the ASEAN region, organised by Informa…

20 ต.ค. 65 9:512022-10-20

thaipr.net

20 ต.ค. 65

On World Osteoporosis Day, take five steps to better bone health

Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention. Osteoporosis is a bone disease that affects some 500 million people worldwide and is a major cause of pain, disability and loss of independence in […]

20 ต.ค. 65 8:15

thaipr.net

20 ต.ค. 65

EDAN Forays into Molecular Point-of-Care Market with Its First-Ever Molecular Diagnostics Solution Released at Medlab Asia 2022

Developed based on Loop-Mediated Isothermal Amplification (LAMP), the new molecular diagnostics analysis system, ClariLight CL30, gives on-the-spot results and empowers physicians for early…

20 ต.ค. 65 8:00

thaipr.net

20 ต.ค. 65

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a first booster dose at least six months after completion of primary vaccination […]

20 ต.ค. 65 8:00

thaipr.net

20 ต.ค. 65